New Possibilities for Protective Arms by Changing the Structure of Angiotensin (1-9)
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Chorev M, Shavitz R, Goodman M, Minick S, Guillemin R
. Partially modified retro-inverso-enkephalinamides: topochemical long-acting analogs in vitro and in vivo. Science. 1979; 204(4398):1210-2.
DOI: 10.1126/science.451565.
View
2.
Santos R, Sampaio W, Alzamora A, Motta-Santos D, Alenina N, Bader M
. The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). Physiol Rev. 2018; 98(1):505-553.
PMC: 7203574.
DOI: 10.1152/physrev.00023.2016.
View
3.
Flores Y, Zapata-Torres G, Nunez A, Matthies D, Aleman L, Hernandez-Fuentes C
. Angiotensin-(1-9) Retro-Enantiomer Peptide With Cardioprotective Activity. Circulation. 2024; 150(10):816-820.
PMC: 11373884.
DOI: 10.1161/CIRCULATIONAHA.122.061322.
View
4.
Norambuena-Soto I, Lopez-Crisosto C, Martinez-Bilbao J, Hernandez-Fuentes C, Parra V, Lavandero S
. Angiotensin-(1-9) in hypertension. Biochem Pharmacol. 2022; 203:115183.
DOI: 10.1016/j.bcp.2022.115183.
View
5.
Wan Y, Wallinder C, Plouffe B, Beaudry H, Mahalingam A, Wu X
. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem. 2004; 47(24):5995-6008.
DOI: 10.1021/jm049715t.
View